BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29574921)

  • 1. Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
    Deng H; Deng X; Liu Y; Xu Y; Lan Y; Gao M; Xu M; Gao H; Wu X; Liao B; Chen W; Zhao M; Hu F; Wang Z
    J Med Virol; 2018 Jul; 90(7):1246-1256. PubMed ID: 29574921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study.
    Ranin J; Salemovic D; Brmbolic B; Marinkovic J; Boricic I; Pesic PI; Zerjav S; Stanojevic M; Jevtovic D
    Curr HIV Res; 2018; 16(3):222-230. PubMed ID: 30014804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.
    Huang SM; Cai WP; Hu FY; Lan Y; Liao BL; Chen YP; Tang XP
    Int J STD AIDS; 2016 Sep; 27(10):890-7. PubMed ID: 26384940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
    Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
    J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and resistance pattern of genotype G and H in chronic hepatitis B and HIV co-infected patients in Mexico.
    Mata Marín JA; Arroyo Anduiza CI; Calderón GM; Cazares Rodríguez S; Fuentes Allen JL; Arias Flores R; Gaytán Martínez J
    Ann Hepatol; 2012; 11(1):47-51. PubMed ID: 22166560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.
    Deressa T; Damtie D; Fonseca K; Gao S; Abate E; Alemu S; Aleka Y; Swain MG; van Marle G; Coffin CS
    PLoS One; 2017; 12(12):e0190149. PubMed ID: 29281718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
    Revill PA; Littlejohn M; Ayres A; Yuen L; Colledge D; Bartholomeusz A; Sasaduesz J; Lewin SR; Dore GJ; Matthews GV; Thio CL; Locarnini SA
    AIDS; 2007 Aug; 21(13):1701-10. PubMed ID: 17690567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon.
    Magoro T; Gachara G; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong P
    Virol J; 2016 Oct; 13(1):178. PubMed ID: 27769271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.
    Lee Z; Nishikawa S; Gao S; Eksteen JB; Czub M; Gill MJ; Osiowy C; van der Meer F; van Marle G; Coffin CS
    PLoS One; 2015; 10(9):e0137568. PubMed ID: 26390290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
    Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
    J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of HBV basic core promoter/pre-core gene mutations and viral quasispecies diversity in HIV/HBV co-infected and HBV mono-infected patients.
    Deng H; Gao H; Liu Y; Xu Y; Yang J; Zhao M; Liu H; Wang Z
    Acta Virol; 2022; 66(1):18-26. PubMed ID: 35380862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China.
    Chen W; Liao B; Hu F; Nie J; Lan Y; Li H; Lu R; Gao Y; Song Y; Zhao Q; Zheng Y; Tang X; Cai W
    PLoS One; 2016; 11(9):e0161844. PubMed ID: 27603929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F; Vincenti D; Vairo F; Solmone M; Mariano A; Piselli P; Puro V; Capobianchi MR; Antonucci G
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
    Belyhun Y; Maier M; Liebert UG
    Antivir Ther; 2017; 22(2):97-111. PubMed ID: 27354181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
    Belyhun Y; Liebert UG; Maier M
    PLoS One; 2018; 13(2):e0191970. PubMed ID: 29408943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.